Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study

  • Jihyung Hong1, 2Email author,
  • Diego Novick2,
  • Roberto Brugnoli3,
  • Jamie Karagianis4,
  • Martin Dossenbach5 and
  • Josep Maria Haro6
BMC Psychiatry201212:218

DOI: 10.1186/1471-244X-12-218

Received: 4 November 2011

Accepted: 28 November 2012

Published: 4 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
4 Nov 2011 Submitted Original manuscript
24 Nov 2011 Author responded Author comments - Jihyung Hong
Resubmission - Version 2
24 Nov 2011 Submitted Manuscript version 2
18 Mar 2012 Reviewed Reviewer Report - Kia-Chong Chua
9 Apr 2012 Reviewed Reviewer Report - Mauro Giovanni Carta
6 Jul 2012 Author responded Author comments - Jihyung Hong
Resubmission - Version 3
6 Jul 2012 Submitted Manuscript version 3
29 Aug 2012 Reviewed Reviewer Report - Mauro Giovanni Carta
23 Oct 2012 Author responded Author comments - Jihyung Hong
Resubmission - Version 4
23 Oct 2012 Submitted Manuscript version 4
30 Oct 2012 Reviewed Reviewer Report - Kia-Chong Chua
10 Nov 2012 Reviewed Reviewer Report - Mauro Giovanni Carta
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
28 Nov 2012 Editorially accepted
4 Dec 2012 Article published 10.1186/1471-244X-12-218

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Personal Social Services Research Unit, London School of Economics and Political Science
(2)
European Health Outcomes Research, Eli Lilly and Company
(3)
Fondazione Italiana per lo studio della Schizophrenia
(4)
Eli Lilly Canada Inc
(5)
Eli Lilly Ges.m.b.H
(6)
Parc Sanitari Sant Joan de Deu, CIBERSAM, Sant Boi de Llobregat

Advertisement